The US Food and Drug Administration (FDA) on Friday approved the use of an advanced breast cancer drug that targets tumor cells. The drug Kadcyla is produced by Roche. Kadcyla combines the popular breast cancer drug Herceptin with a powerful chemotherapy drug. The drug then uses a third chemical to link those two drugs together…. Read more »

